Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Moccia

Showing results (111-120 of 221) with videos related to

Pageof 23
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|January 8, 2016
Serum uric acid is associated with apathy in early, drug-naïve Parkinson's diseaseMarina Picillo, Gabriella Santangelo, Marcello Moccia, et al.
European Journal of Neurology|October 22, 2020
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosisMartina Petruzzo, Antonio Reia, Giorgia T Maniscalco, et al.
Multiple Sclerosis and Related Disorders|February 8, 2021
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosisNicola Capasso, Agostino Nozzolillo, Giulia Scalia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 6, 2019
Correction to: Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and educationFabrizia Falco, Marcello Moccia, Alessandro Chiodi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's diseaseRoberto Erro, Marina Picillo, Marianna Amboni, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.
BMC Geriatrics|March 11, 2025
Barriers for access and utilization of dementia care services in Europe: a systematic reviewMichele Sorrentino, Claudio Fiorilla, Michelangelo Mercogliano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 6, 2023
Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based StudyGiuseppina Affinito, Ugo Trama, Laura Palumbo, et al.
Journal of Neurology|February 13, 2013
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's diseaseMarina Picillo, Roberto Erro, Gabriella Santangelo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 16, 2019
Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and educationFabrizia Falco, Marcello Moccia, Alessandro Chiodi, et al.
Pageof 23

Showing results (111-120 of 221) with videos related to

Sort By:
Pageof 23
Journal of Neural Transmission (Vienna, Austria : 1996)|January 8, 2016
Serum uric acid is associated with apathy in early, drug-naïve Parkinson's diseaseMarina Picillo, Gabriella Santangelo, Marcello Moccia, et al.
European Journal of Neurology|October 22, 2020
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosisMartina Petruzzo, Antonio Reia, Giorgia T Maniscalco, et al.
Multiple Sclerosis and Related Disorders|February 8, 2021
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosisNicola Capasso, Agostino Nozzolillo, Giulia Scalia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 6, 2019
Correction to: Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and educationFabrizia Falco, Marcello Moccia, Alessandro Chiodi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's diseaseRoberto Erro, Marina Picillo, Marianna Amboni, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.
BMC Geriatrics|March 11, 2025
Barriers for access and utilization of dementia care services in Europe: a systematic reviewMichele Sorrentino, Claudio Fiorilla, Michelangelo Mercogliano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 6, 2023
Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based StudyGiuseppina Affinito, Ugo Trama, Laura Palumbo, et al.
Journal of Neurology|February 13, 2013
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's diseaseMarina Picillo, Roberto Erro, Gabriella Santangelo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 16, 2019
Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and educationFabrizia Falco, Marcello Moccia, Alessandro Chiodi, et al.
Pageof 23